These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 32673663)

  • 1. Docosahexaenoic acid (DHA) inhibits pro-angiogenic effects of breast cancer cells via down-regulating cellular and exosomal expression of angiogenic genes and microRNAs.
    Aslan C; Maralbashi S; Kahroba H; Asadi M; Soltani-Zangbar MS; Javadian M; Shanehbandi D; Baradaran B; Darabi M; Kazemi T
    Life Sci; 2020 Oct; 258():118094. PubMed ID: 32673663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosome-mediated microRNA signaling from breast cancer cells is altered by the anti-angiogenesis agent docosahexaenoic acid (DHA).
    Hannafon BN; Carpenter KJ; Berry WL; Janknecht R; Dooley WC; Ding WQ
    Mol Cancer; 2015 Jul; 14():133. PubMed ID: 26178901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Docosahexaenoic acid reverses the promoting effects of breast tumor cell-derived exosomes on endothelial cell migration and angiogenesis.
    Ghaffari-Makhmalbaf P; Sayyad M; Pakravan K; Razmara E; Bitaraf A; Bakhshinejad B; Goudarzi P; Yousefi H; Pournaghshband M; Nemati F; Fahimi H; Rohollah F; Hasanzad M; Hashemi M; Mousavi SH; Babashah S
    Life Sci; 2021 Jan; 264():118719. PubMed ID: 33159957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-100 shuttled by mesenchymal stem cell-derived exosomes suppresses in vitro angiogenesis through modulating the mTOR/HIF-1α/VEGF signaling axis in breast cancer cells.
    Pakravan K; Babashah S; Sadeghizadeh M; Mowla SJ; Mossahebi-Mohammadi M; Ataei F; Dana N; Javan M
    Cell Oncol (Dordr); 2017 Oct; 40(5):457-470. PubMed ID: 28741069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Docosahexaenoic acid suppresses migration of triple-negative breast cancer cell through targeting metastasis-related genes and microRNA under normoxic and hypoxic conditions.
    Javadian M; Shekari N; Soltani-Zangbar MS; Mohammadi A; Mansoori B; Maralbashi S; Shanehbandi D; Baradaran B; Darabi M; Kazemi T
    J Cell Biochem; 2020 Mar; 121(3):2416-2427. PubMed ID: 31713924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of docosahexaenoic acid (DHA) and linoleic acid (LA) on miR-101 and miR-342 tumor suppressor microRNAs in Taxol-treated HER2-positive breast cancer cells.
    Aslan C; Maralbashi S; Shekari N; Javadian M; Shomali N; Kazemi T
    Clin Nutr ESPEN; 2024 Oct; 63():502-507. PubMed ID: 39047867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cisplatin-resistant MDA-MB-231 Cell-derived Exosomes Increase the Resistance of Recipient Cells in an Exosomal miR-423-5p-dependent Manner.
    Wang B; Zhang Y; Ye M; Wu J; Ma L; Chen H
    Curr Drug Metab; 2019; 20(10):804-814. PubMed ID: 31424364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of exosomal miR-9 and miR-155 targeting PTEN and DUSP14 in highly metastatic breast cancer and their effect on low metastatic cells.
    Kia V; Paryan M; Mortazavi Y; Biglari A; Mohammadi-Yeganeh S
    J Cell Biochem; 2019 Apr; 120(4):5666-5676. PubMed ID: 30335891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosome-mediated transfer of miR-10b promotes cell invasion in breast cancer.
    Singh R; Pochampally R; Watabe K; Lu Z; Mo YY
    Mol Cancer; 2014 Nov; 13():256. PubMed ID: 25428807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Docosahexaenoic acid (DHA) and linoleic acid (LA) modulate the expression of breast cancer involved miRNAs in MDA-MB-231 cell line.
    Elieh Ali Komi D; Shekari N; Soofian-Kordkandi P; Javadian M; Shanehbandi D; Baradaran B; Kazemi T
    Clin Nutr ESPEN; 2021 Dec; 46():477-483. PubMed ID: 34857238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer-derived exosomal miR-221-3p promotes angiogenesis by targeting THBS2 in cervical squamous cell carcinoma.
    Wu XG; Zhou CF; Zhang YM; Yan RM; Wei WF; Chen XJ; Yi HY; Liang LJ; Fan LS; Liang L; Wu S; Wang W
    Angiogenesis; 2019 Aug; 22(3):397-410. PubMed ID: 30993566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiogenic role of miR-20a in breast cancer.
    Luengo-Gil G; Gonzalez-Billalabeitia E; Perez-Henarejos SA; Navarro Manzano E; Chaves-Benito A; Garcia-Martinez E; Garcia-Garre E; Vicente V; Ayala de la Peña F
    PLoS One; 2018; 13(4):e0194638. PubMed ID: 29617404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosomal release of microRNA-454 by breast cancer cells sustains biological properties of cancer stem cells via the PRRT2/Wnt axis in ovarian cancer.
    Wang L; He M; Fu L; Jin Y
    Life Sci; 2020 Sep; 257():118024. PubMed ID: 32598931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Horizontal transfer of miR-23a from hypoxic tumor cell colonies can induce angiogenesis.
    Sruthi TV; Edatt L; Raji GR; Kunhiraman H; Shankar SS; Shankar V; Ramachandran V; Poyyakkara A; Kumar SVB
    J Cell Physiol; 2018 Apr; 233(4):3498-3514. PubMed ID: 28929578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Docosahexaenoic acid (DHA) impairs hypoxia-induced cellular and exosomal overexpression of immune-checkpoints and immunomodulatory molecules in different subtypes of breast cancer cells.
    Maralbashi S; Aslan C; Kahroba H; Asadi M; Soltani-Zangbar MS; Haghnavaz N; Jadidi F; Salari F; Kazemi T
    BMC Nutr; 2024 Mar; 10(1):41. PubMed ID: 38439112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma exosome microRNAs are indicative of breast cancer.
    Hannafon BN; Trigoso YD; Calloway CL; Zhao YD; Lum DH; Welm AL; Zhao ZJ; Blick KE; Dooley WC; Ding WQ
    Breast Cancer Res; 2016 Sep; 18(1):90. PubMed ID: 27608715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant canine mammary epithelial cells shed exosomes containing differentially expressed microRNA that regulate oncogenic networks.
    Fish EJ; Irizarry KJ; DeInnocentes P; Ellis CJ; Prasad N; Moss AG; Curt Bird R
    BMC Cancer; 2018 Aug; 18(1):832. PubMed ID: 30126376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal stem cell-derived exosomes enriched with miR-218 reduce the epithelial-mesenchymal transition and angiogenesis in triple-negative breast cancer cells.
    Shojaei S; Moradi-Chaleshtori M; Paryan M; Koochaki A; Sharifi K; Mohammadi-Yeganeh S
    Eur J Med Res; 2023 Nov; 28(1):516. PubMed ID: 37968694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxic lung cancer-secreted exosomal miR-23a increased angiogenesis and vascular permeability by targeting prolyl hydroxylase and tight junction protein ZO-1.
    Hsu YL; Hung JY; Chang WA; Lin YS; Pan YC; Tsai PH; Wu CY; Kuo PL
    Oncogene; 2017 Aug; 36(34):4929-4942. PubMed ID: 28436951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of cellular exosomes as a new carrier in breast cancer gene therapy.
    Maleki N; Mirhakimi S; Babashah S; Sayadi A; Parnian G; Hadizadeh M
    Klin Onkol; 2021; 34(4):300-305. PubMed ID: 34649440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.